Skip to main content
. 2017 Nov 9;117(12):1768–1776. doi: 10.1038/bjc.2017.382

Figure 1.

Figure 1

Trial profiles for CAIRO3 and AIO 0207. IPD = individual patient data; OS = overall survival; PFS1 = first progression-free survival; PFS2 = second progression-free survival.